Literature DB >> 23707226

Older patient age may predict early mortality after transjugular intrahepatic portosystemic shunt creation in individuals at intermediate risk.

Ahmad Parvinian1, Kruti D Shah, Patrick M Couture, Jeet Minocha, M Grace Knuttinen, James T Bui, Ron C Gaba.   

Abstract

PURPOSE: To identify prognostic factors for early mortality among patients with intermediate-risk Model for End-stage Liver Disease (MELD) scores undergoing transjugular intrahepatic portosystemic shunt (TIPS) creation.
MATERIALS AND METHODS: In this single-institution retrospective study, 47 patients (31 men; mean age, 54 y) with intermediate MELD scores (ie, 18-25) underwent TIPS creation between 1999 and 2012. Medical records were reviewed to identify demographic (age, sex), liver disease (Child-Pugh, MELD), and procedure data (indication, urgency, stent type, portosystemic pressure gradient reduction, complications), and the influence of these parameters on 90-day mortality was assessed by multivariate binary logistic regression analysis.
RESULTS: TIPSs were successfully created for variceal hemorrhage (n = 24), ascites (n = 17), hydrothorax (n = 5), and portal vein thrombosis (n = 1). Hemodynamic success rate was 94% (44 of 47), and mean portosystemic pressure gradient reduction was 13 mm Hg. The 90-day mortality rate was 36% (17 of 47). Patient age (P = .026) was significantly associated with 90-day mortality. Mean ages of living versus dead patients were 51 and 60 years, and mortality rates in patients aged 54 years or younger versus 55 years or older were 21% (five of 24) and 52% (12 of 23), respectively. There was no difference in MELD scores between these age groups (20.6 vs 21.0; P = .600), and MELD score was not a predictive factor on regression analysis.
CONCLUSIONS: Age is a prognostic factor for early mortality in TIPS recipients with intermediate MELD scores. Mortality rates are higher in patients at least 55 years of age, but MELD score does not predict survival in this subset. Age should be contemplated when selecting patients at intermediate risk for TIPS creation.
Copyright © 2013 SIR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23707226     DOI: 10.1016/j.jvir.2013.03.018

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  5 in total

1.  Primary constrained TIPS for treating refractory ascites or variceal bleeding secondary to hepatic cirrhosis.

Authors:  R Rabei; S Mathevosian; J Tasse; S Madassery; B Arslan; U Turba; O Ahmed
Journal:  Br J Radiol       Date:  2017-12-15       Impact factor: 3.039

2.  Predictors of mortality after transjugular portosystemic shunt.

Authors:  Mona Ascha; Sami Abuqayyas; Ibrahim Hanouneh; Laith Alkukhun; Mark Sands; Raed A Dweik; Adriano R Tonelli
Journal:  World J Hepatol       Date:  2016-04-18

3.  Long-term patency and clinical outcome of the transjugular intrahepatic portosystemic shunt using the expanded polytetrafluoroethylene stent-graft.

Authors:  Xuefeng Luo; Ming Zhao; Xiaoze Wang; Mingshan Jiang; Jiaze Yu; Xiao Li; Li Yang
Journal:  PLoS One       Date:  2019-02-27       Impact factor: 3.240

Review 4.  Cirrhotic patients and older people.

Authors:  Paul Carrier; Marilyne Debette-Gratien; Jérémie Jacques; Véronique Loustaud-Ratti
Journal:  World J Hepatol       Date:  2019-09-27

5.  Outcomes After Transjugular Intrahepatic Portosystemic Shunt in Cirrhotic Patients 70 Years and Older.

Authors:  Natasha Adlakha; Mark W Russo
Journal:  J Clin Med       Date:  2020-01-31       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.